Nuveen, LLC Uro Gen Pharma Ltd. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Nuveen, LLC holds 92,957 shares of URGN stock, worth $1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
92,957Holding current value
$1 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding URGN
# of Institutions
135Shares Held
36.4MCall Options Held
57.7KPut Options Held
9.8K-
Rtw Investments, LP New York, NY3.83MShares$41.5 Million0.67% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.93MShares$31.7 Million0.06% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$24.9 Million0.17% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$23.7 Million0.0% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A61.75MShares$18.9 Million0.03% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $246M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...